Article ID Journal Published Year Pages File Type
2514492 Biochemical Pharmacology 2009 11 Pages PDF
Abstract

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that belongs to the basic helix-loop-helix/Per-ARNT-Sim (bHLH-PAS) family. Its ligands include many natural and synthetic compounds, some of which, such as polyhalogenated aromatic hydrocarbons and polycyclic aromatic hydrocarbons, are important environmental contaminants. NF-κB is a pleiotropic factor that regulates many physiological and pathophysiological processes including the immune and inflammatory responses. In the past decade, accumulating evidence suggests close interactions between AhR and NF-κB pathways, and these interactions are potentially important mechanisms for many pathological processes such as the chemical-induced immune dysfunctions, carcinogenesis and alteration of xenobiotic metabolism and disposition. AhR–NF-κB interaction has become a mechanistic linchpin linking certain pathological responses induced by environmental insults. Furthermore, the AhR–NF-κB interaction provides basis for therapeutic applications of certain AhR ligands to treat human diseases. The effects of AhR–NF-κB on the epigenome are an important area that is not well understood. In this review, I highlight current research regarding the AhR–NF-κB(RelA) interactions with emphasis on the epigenetic impacts of these interactions on chromatin modifications and transcription elongation control.

Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmacology
Authors
,